HJ Research delivers in-depth insights on the global Ankylosing Spondylitis Treatment market in its upcoming report titled, Global Ankylosing Spondylitis Treatment Market Report 2018-2029. According to this study, the global Ankylosing Spondylitis Treatment market is estimated to be valued at XX Million US$ in 2023 and is projected to reach XX Million US$ by 2029, expanding at a CAGR of XX% during the forecast period. The report on Ankylosing Spondylitis Treatment market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, industrial chain, etc.
This report studies the Ankylosing Spondylitis Treatment market status and outlook of global and major regions, from angles of players, countries, product types and end industries, this report analyzes the top players in global Ankylosing Spondylitis Treatment industry, and splits by product type and applications/end industries. This report also includes the impact of COVID-19 on the Ankylosing Spondylitis Treatment industry.
Global Ankylosing Spondylitis Treatment market: competitive landscape analysis
This report contains the major manufacturers analysis of the global Ankylosing Spondylitis Treatment industry. By understanding the operations of these manufacturers (revenue and gross margin from 2018 to 2023), the reader can understand the strategies and collaborations that the manufacturers are focusing on combat competition in the market.
Global Ankylosing Spondylitis Treatment market: types and end industries analysis
The research report includes specific segments such as end industries and product types of Ankylosing Spondylitis Treatment. The report provides market size for each type and end industry from 2018 to 2023. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Global Ankylosing Spondylitis Treatment market: regional analysis
Geographically, this report is segmented into several key countries, with market size, growth rate of Ankylosing Spondylitis Treatment in these countries from 2018 to 2023, which covering United States, Canada, Germany, France, UK, Italy, Russia, Spain, Netherlands, China, Japan, Korea, India, Australia, Indonesia, Vietnam, Turkey, Saudi Arabia, South Africa, Egypt, Brazil, Mexico, Argentina, Colombia.
Key players in global Ankylosing Spondylitis Treatment market include:
Abbvie
Amgen
Janssen Biotech
Merck
UCB
Boehringer Ingelheim
Johnson & Johnson
Market segmentation, by product types:
Disease-Modifying Anitrheumatic Drugs (DMARDs)
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Biologics
Market segmentation, by applications:
Juveniles
Adults
1 Industry Overview of Ankylosing Spondylitis Treatment
1.1 Research Scope
1.2 Market Segmentation by Types of Ankylosing Spondylitis Treatment
1.3 Market Segmentation by End Users of Ankylosing Spondylitis Treatment
1.4 Market Dynamics Analysis of Ankylosing Spondylitis Treatment
1.4.1 Market Drivers
1.4.2 Market Challenges
1.4.3 Market Opportunities
1.4.4 Porter’s Five Forces
2 Major Manufacturers Analysis of Ankylosing Spondylitis Treatment Industry
2.1 Abbvie
2.1.1 Company Overview
2.1.2 Main Products and Specifications
2.1.3 Ankylosing Spondylitis Treatment Revenue and Gross Margin (2018-2023)
2.1.4 Contact Information
2.2 Amgen
2.2.1 Company Overview
2.2.2 Main Products and Specifications
2.2.3 Ankylosing Spondylitis Treatment Revenue and Gross Margin (2018-2023)
2.2.4 Contact Information
2.3 Janssen Biotech
2.3.1 Company Overview
2.3.2 Main Products and Specifications
2.3.3 Ankylosing Spondylitis Treatment Revenue and Gross Margin (2018-2023)
2.3.4 Contact Information
2.4 Merck
2.4.1 Company Overview
2.4.2 Main Products and Specifications
2.4.3 Ankylosing Spondylitis Treatment Revenue and Gross Margin (2018-2023)
2.4.4 Contact Information
2.5 UCB
2.5.1 Company Overview
2.5.2 Main Products and Specifications
2.5.3 Ankylosing Spondylitis Treatment Revenue and Gross Margin (2018-2023)
2.5.4 Contact Information
2.6 Boehringer Ingelheim
2.6.1 Company Overview
2.6.2 Main Products and Specifications
2.6.3 Ankylosing Spondylitis Treatment Revenue and Gross Margin (2018-2023)
2.6.4 Contact Information
2.7 Johnson & Johnson
2.7.1 Company Overview
2.7.2 Main Products and Specifications
2.7.3 Ankylosing Spondylitis Treatment Revenue and Gross Margin (2018-2023)
2.7.4 Contact Information
3 Global Ankylosing Spondylitis Treatment Market Analysis by Regions, Manufacturers, Types and End Users
3.1 Global Sales Revenue of Ankylosing Spondylitis Treatment by Regions (2018-2023)
3.2 Global Sales Revenue of Ankylosing Spondylitis Treatment by Manufacturers (2018-2023)
3.3 Global Sales Revenue of Ankylosing Spondylitis Treatment by Types (2018-2023)
3.4 Global Sales Revenue of Ankylosing Spondylitis Treatment by End Users (2018-2023)
4 Northern America Ankylosing Spondylitis Treatment Market Analysis by Countries, Types and End Users
4.1 Northern America Ankylosing Spondylitis Treatment Sales Revenue Analysis by Countries (2018-2023)
4.2 Northern America Ankylosing Spondylitis Treatment Sales Revenue Analysis by Types (2018-2023)
4.3 Northern America Ankylosing Spondylitis Treatment Sales Revenue Analysis by End Users (2018-2023)
4.4 United States Ankylosing Spondylitis Treatment Sales Revenue Analysis (2018-2023)
4.5 Canada Ankylosing Spondylitis Treatment Sales Revenue Analysis (2018-2023)
5 Europe Ankylosing Spondylitis Treatment Market Analysis by Countries, Types and End Users
5.1 Europe Ankylosing Spondylitis Treatment Sales Revenue Analysis by Countries (2018-2023)
5.2 Europe Ankylosing Spondylitis Treatment Sales Revenue Analysis by Types (2018-2023)
5.3 Europe Ankylosing Spondylitis Treatment Sales Revenue Analysis by End Users (2018-2023)
5.4 Germany Ankylosing Spondylitis Treatment Sales Revenue Analysis (2018-2023)
5.5 France Ankylosing Spondylitis Treatment Sales Revenue Analysis (2018-2023)
5.6 UK Ankylosing Spondylitis Treatment Sales Revenue Analysis (2018-2023)
5.7 Italy Ankylosing Spondylitis Treatment Sales Revenue Analysis (2018-2023)
5.8 Russia Ankylosing Spondylitis Treatment Sales Revenue Analysis (2018-2023)
5.9 Spain Ankylosing Spondylitis Treatment Sales Revenue Analysis (2018-2023)
5.10 Netherlands Ankylosing Spondylitis Treatment Sales Revenue Analysis (2018-2023)
6 Asia Pacific Ankylosing Spondylitis Treatment Market Analysis by Countries, Types and End Users
6.1 Asia Pacific Ankylosing Spondylitis Treatment Sales Revenue Analysis by Countries (2018-2023)
6.2 Asia Pacific Ankylosing Spondylitis Treatment Sales Revenue Analysis by Types (2018-2023)
6.3 Asia Pacific Ankylosing Spondylitis Treatment Sales Revenue Analysis by End Users (2018-2023)
6.4 China Ankylosing Spondylitis Treatment Sales Revenue Analysis (2018-2023)
6.5 Japan Ankylosing Spondylitis Treatment Sales Revenue Analysis (2018-2023)
6.6 Korea Ankylosing Spondylitis Treatment Sales Revenue Analysis (2018-2023)
6.7 India Ankylosing Spondylitis Treatment Sales Revenue Analysis (2018-2023)
6.8 Australia Ankylosing Spondylitis Treatment Sales Revenue Analysis (2018-2023)
6.9 Indonesia Ankylosing Spondylitis Treatment Sales Revenue Analysis (2018-2023)
6.10 Vietnam Ankylosing Spondylitis Treatment Sales Revenue Analysis (2018-2023)
7 Latin America Ankylosing Spondylitis Treatment Market Analysis by Countries, Types and End Users
7.1 Latin America Ankylosing Spondylitis Treatment Sales Revenue Analysis by Countries (2018-2023)
7.2 Latin America Ankylosing Spondylitis Treatment Sales Revenue Analysis by Types (2018-2023)
7.3 Latin America Ankylosing Spondylitis Treatment Sales Revenue Analysis by End Users (2018-2023)
7.4 Brazil Ankylosing Spondylitis Treatment Sales Revenue Analysis (2018-2023)
7.5 Mexico Ankylosing Spondylitis Treatment Sales Revenue Analysis (2018-2023)
7.6 Argentina Ankylosing Spondylitis Treatment Sales Revenue Analysis (2018-2023)
7.7 Colombia Ankylosing Spondylitis Treatment Sales Revenue Analysis (2018-2023)
8 Middle East & Africa Ankylosing Spondylitis Treatment Market Analysis by Countries, Types and End Users
8.1 Middle East & Africa Ankylosing Spondylitis Treatment Sales Revenue Analysis by Countries (2018-2023)
8.2 Middle East & Africa Ankylosing Spondylitis Treatment Sales Revenue Analysis by Types (2018-2023)
8.3 Middle East & Africa Ankylosing Spondylitis Treatment Sales Revenue Analysis by End Users (2018-2023)
8.4 Turkey Ankylosing Spondylitis Treatment Sales Revenue Analysis (2018-2023)
8.5 Saudi Arabia Ankylosing Spondylitis Treatment Sales Revenue Analysis (2018-2023)
8.6 South Africa Ankylosing Spondylitis Treatment Sales Revenue Analysis (2018-2023)
8.7 Egypt Ankylosing Spondylitis Treatment Sales Revenue Analysis (2018-2023)
9 Marketing Channel, Distributors and Traders Analysis
9.1 Marketing Channel
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Distributors and Traders
10 Global Ankylosing Spondylitis Treatment Market Forecast by Regions, Countries, Manufacturers, Types and End Users
10.1 Global Sales Revenue Forecast of Ankylosing Spondylitis Treatment by Regions (2024-2029)
10.2 Global Sales Revenue Forecast of Ankylosing Spondylitis Treatment by Types (2024-2029)
10.3 Global Sales Revenue Forecast of Ankylosing Spondylitis Treatment by End Users (2024-2029)
10.4 Global Revenue Forecast of Ankylosing Spondylitis Treatment by Countries (2024-2029)
10.4.1 United States Revenue Forecast (2024-2029)
10.4.2 Canada Revenue Forecast (2024-2029)
10.4.3 Germany Revenue Forecast (2024-2029)
10.4.4 France Revenue Forecast (2024-2029)
10.4.5 UK Revenue Forecast (2024-2029)
10.4.6 Italy Revenue Forecast (2024-2029)
10.4.7 Russia Revenue Forecast (2024-2029)
10.4.8 Spain Revenue Forecast (2024-2029)
10.4.9 Netherlands Revenue Forecast (2024-2029)
10.4.10 China Revenue Forecast (2024-2029)
10.4.11 Japan Revenue Forecast (2024-2029)
10.4.12 Korea Revenue Forecast (2024-2029)
10.4.13 India Revenue Forecast (2024-2029)
10.4.14 Australia Revenue Forecast (2024-2029)
10.4.15 Indonesia Revenue Forecast (2024-2029)
10.4.16 Vietnam Revenue Forecast (2024-2029)
10.4.17 Brazil Revenue Forecast (2024-2029)
10.4.18 Mexico Revenue Forecast (2024-2029)
10.4.19 Argentina Revenue Forecast (2024-2029)
10.4.20 Colombia Revenue Forecast (2024-2029)
10.4.21 Turkey Revenue Forecast (2024-2029)
10.4.22 Saudi Arabia Revenue Forecast (2024-2029)
10.4.23 South Africa Revenue Forecast (2024-2029)
10.4.24 Egypt Revenue Forecast (2024-2029)
11 Industry Chain Analysis of Ankylosing Spondylitis Treatment
11.1 Upstream Analysis of Ankylosing Spondylitis Treatment
11.2 Downstream Major Consumers Analysis of Ankylosing Spondylitis Treatment
11.3 Major Suppliers of Ankylosing Spondylitis Treatment with Contact Information
11.4 Supply Chain Relationship Analysis of Ankylosing Spondylitis Treatment
12 Ankylosing Spondylitis Treatment New Project Investment Feasibility Analysis
12.1 Ankylosing Spondylitis Treatment New Project SWOT Analysis
12.2 Ankylosing Spondylitis Treatment New Project Investment Feasibility Analysis
12.2.1 Project Name
12.2.2 Investment Budget
12.2.3 Project Product Solutions
12.2.4 Project Schedule
13 Ankylosing Spondylitis Treatment Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.2 References and Data Sources
14.2.1 Primary Sources
14.2.2 Secondary Paid Sources
14.2.3 Secondary Public Sources
14.3 Abbreviations and Units of Measurement
14.4 Author Details
14.5 Disclaimer
Table Types of Ankylosing Spondylitis Treatment
Table End Users of Ankylosing Spondylitis Treatment
Figure Market Drivers Analysis of Ankylosing Spondylitis Treatment
Figure Market Challenges Analysis of Ankylosing Spondylitis Treatment
Figure Market Opportunities Analysis of Ankylosing Spondylitis Treatment
Table Market Drivers Analysis of Ankylosing Spondylitis Treatment
Table Abbvie Information List
Figure Ankylosing Spondylitis Treatment Specifications of Abbvie
Table Ankylosing Spondylitis Treatment Revenue (Million USD) and Gross Margin of Abbvie (2018-2023)
Figure Ankylosing Spondylitis Treatment Revenue (Million USD) and Global Market Share of Abbvie (2018-2023)
Table Amgen Information List
Figure Ankylosing Spondylitis Treatment Specifications of Amgen
Table Ankylosing Spondylitis Treatment Revenue (Million USD) and Gross Margin of Amgen (2018-2023)
Figure Ankylosing Spondylitis Treatment Revenue (Million USD) and Global Market Share of Amgen (2018-2023)
Table Janssen Biotech Information List
Figure Ankylosing Spondylitis Treatment Specifications of Janssen Biotech
Table Ankylosing Spondylitis Treatment Revenue (Million USD) and Gross Margin of Janssen Biotech (2018-2023)
Figure Ankylosing Spondylitis Treatment Revenue (Million USD) and Global Market Share of Janssen Biotech (2018-2023)
Table Merck Information List
Figure Ankylosing Spondylitis Treatment Specifications of Merck
Table Ankylosing Spondylitis Treatment Revenue (Million USD) and Gross Margin of Merck (2018-2023)
Figure Ankylosing Spondylitis Treatment Revenue (Million USD) and Global Market Share of Merck (2018-2023)
Table UCB Information List
Figure Ankylosing Spondylitis Treatment Specifications of UCB
Table Ankylosing Spondylitis Treatment Revenue (Million USD) and Gross Margin of UCB (2018-2023)
Figure Ankylosing Spondylitis Treatment Revenue (Million USD) and Global Market Share of UCB (2018-2023)
Table Boehringer Ingelheim Information List
Figure Ankylosing Spondylitis Treatment Specifications of Boehringer Ingelheim
Table Ankylosing Spondylitis Treatment Revenue (Million USD) and Gross Margin of Boehringer Ingelheim (2018-2023)
Figure Ankylosing Spondylitis Treatment Revenue (Million USD) and Global Market Share of Boehringer Ingelheim (2018-2023)
Table Johnson & Johnson Information List
Figure Ankylosing Spondylitis Treatment Specifications of Johnson & Johnson
Table Ankylosing Spondylitis Treatment Revenue (Million USD) and Gross Margin of Johnson & Johnson (2018-2023)
Figure Ankylosing Spondylitis Treatment Revenue (Million USD) and Global Market Share of Johnson & Johnson (2018-2023)
Table Global Revenue (Million USD) of Ankylosing Spondylitis Treatment by Regions (2018-2023)
Table Global Revenue (Million USD) of Ankylosing Spondylitis Treatment by Manufacturers (2018-2023)
Table Global Revenue (Million USD) of Ankylosing Spondylitis Treatment by Types (2018-2023)
Table Global Revenue (Million USD) of Ankylosing Spondylitis Treatment by End Users (2018-2023)
Table Northern America Ankylosing Spondylitis Treatment Revenue (Million USD) by Countries (2018-2023)
Table Northern America Ankylosing Spondylitis Treatment Revenue (Million USD) by Types (2018-2023)
Table Northern America Ankylosing Spondylitis Treatment Revenue (Million USD) by End Users (2018-2023)
Figure United States Ankylosing Spondylitis Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure Canada Ankylosing Spondylitis Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Table Europe Ankylosing Spondylitis Treatment Revenue (Million USD) by Countries (2018-2023)
Table Europe Ankylosing Spondylitis Treatment Revenue (Million USD) by Types (2018-2023)
Table Europe Ankylosing Spondylitis Treatment Revenue (Million USD) by End Users (2018-2023)
Figure Germany Ankylosing Spondylitis Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure France Ankylosing Spondylitis Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure UK Ankylosing Spondylitis Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure Italy Ankylosing Spondylitis Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure Russia Ankylosing Spondylitis Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure Spain Ankylosing Spondylitis Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure Netherlands Ankylosing Spondylitis Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Table Asia Pacific Ankylosing Spondylitis Treatment Revenue (Million USD) by Countries (2018-2023)
Table Asia Pacific Ankylosing Spondylitis Treatment Revenue (Million USD) by Types (2018-2023)
Table Asia Pacific Ankylosing Spondylitis Treatment Revenue (Million USD) by End Users (2018-2023)
Figure China Ankylosing Spondylitis Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure Japan Ankylosing Spondylitis Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure Korea Ankylosing Spondylitis Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure India Ankylosing Spondylitis Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure Australia Ankylosing Spondylitis Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure Indonesia Ankylosing Spondylitis Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure Vietnam Ankylosing Spondylitis Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Table Latin America Ankylosing Spondylitis Treatment Revenue (Million USD) by Countries (2018-2023)
Table Latin America Ankylosing Spondylitis Treatment Revenue (Million USD) by Types (2018-2023)
Table Latin America Ankylosing Spondylitis Treatment Revenue (Million USD) by End Users (2018-2023)
Figure Brazil Ankylosing Spondylitis Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure Mexico Ankylosing Spondylitis Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure Argentina Ankylosing Spondylitis Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure Colombia Ankylosing Spondylitis Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Table Middle East & Africa Ankylosing Spondylitis Treatment Revenue (Million USD) by Countries (2018-2023)
Table Middle East & Africa Ankylosing Spondylitis Treatment Revenue (Million USD) by Types (2018-2023)
Table Middle East & Africa Ankylosing Spondylitis Treatment Revenue (Million USD) by End Users (2018-2023)
Figure Turkey Ankylosing Spondylitis Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure Saudi Arabia Ankylosing Spondylitis Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure South Africa Ankylosing Spondylitis Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Figure Egypt Ankylosing Spondylitis Treatment Revenue (Million USD) and Growth Rate (2018-2023)
Table Global Revenue (Million USD) Forecast of Ankylosing Spondylitis Treatment by Regions (2024-2029)
Table Global Revenue (Million USD) Forecast of Ankylosing Spondylitis Treatment by Types (2024-2029)
Table Global Revenue (Million USD) Forecast of Ankylosing Spondylitis Treatment by End Users (2024-2029)
Table Major Consumers with Contact Information of Ankylosing Spondylitis Treatment
Table Major Suppliers of Ankylosing Spondylitis Treatment with Contact Information
Figure Supply Chain Relationship Analysis of Ankylosing Spondylitis Treatment
Table New Project SWOT Analysis of Ankylosing Spondylitis Treatment
Table Project Appraisal and Financing
Table New Project Construction Period
Table New Project Investment Feasibility Analysis of Ankylosing Spondylitis Treatment
Table Research Programs/Design for This Report
Table Key Data Information from Primary Sources
Table Key Data Information from Secondary Sources
Table Part of Interviewees Record List of Ankylosing Spondylitis Treatment Industry
Table Part of References List of Ankylosing Spondylitis Treatment Industry
Table Units of Measurement List
Table Part of Author Details List of Ankylosing Spondylitis Treatment Industry
HJ Research employs comprehensive and iterative research methodology focused on minimizing deviance in order to provide the most accurate estimates and forecast possible. At HJ Research, our researchers and domain experts use a unique blend of primary and secondary research, with validation and iterations at every stage, in order to minimize deviation and present the most accurate analysis of the Ankylosing Spondylitis Treatment industry. Critical elements of methodology employed for all our studies include:
Secondary Sources:
The research team first works with national bureau of statistics, national customs, market research association, state information center, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Secondary sources are mainly from press releases, company reports and publications, non-profit organizations, industry associations, government publications, economic and demographic data and customs data. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.
Primary Research:
In the primary research process, for comprehensive understanding of the Ankylosing Spondylitis Treatment market, it is essential to understand the complete value chain and in order to facilitate this, we collect data from Ankylosing Spondylitis Treatment manufacturers, Ankylosing Spondylitis Treatment raw material suppliers, Ankylosing Spondylitis Treatment distributors as well as buyers. The primary sources from the supply side include Ankylosing Spondylitis Treatment manufacturers, opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the Ankylosing Spondylitis Treatment raw materials suppliers and producers, etc. The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users, and related key executives from various key companies and organizations operating in the global market.
Technical issues and trends are obtained from surveys, technical symposia and trade journals. Technical data is also gathered from intellectual property perspective, focusing on white space and freedom of movement. Industry dynamics with respect to drivers, restraints, pricing trends are also gathered.
Statistical Model and Data Analysis:
Our market estimates and forecasts are derived through simulation models. A unique model is created customized for each study. Gathered information for market dynamics, technology landscape, application development and pricing trends is fed into the model and analyzed simultaneously. These factors are studied on a comparative basis, and their impact over the forecast period is quantified with the help of correlation, regression and time series analysis. Market forecasting is performed via a combination of economic tools, technological analysis, and industry experience and domain expertise. Qualitative analysis includes: Ankylosing Spondylitis Treatment industry landscape and trends, Ankylosing Spondylitis Treatment market dynamics and key issues, Ankylosing Spondylitis Treatment technology landscape, market opportunities, porter’s analysis and PESTEL analysis, Ankylosing Spondylitis Treatment competitive landscape and component benchmarking, policy and regulatory scenario. Quantitative analysis includes: Ankylosing Spondylitis Treatment market size and forecast by regions, Ankylosing Spondylitis Treatment market size and forecast by application, Ankylosing Spondylitis Treatment market size and forecast by types, Ankylosing Spondylitis Treatment company market share etc.
Quality Control:
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the HJ Research’s internal quality process.
